ID
45476
Beschrijving
Principal Investigator: Todd Lencz, PhD, Feinstein Institute for Medical Research, North Shore - LIJ Health System, Manhasset, NY, USA MeSH: Schizophrenia https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000448 Schizophrenia is characterized by high heritability (~80%), yet the identification of susceptibility genes has proven extremely challenging. The Ashkenazi Jewish population, derived from a limited number of founders, may be enriched for a subset of susceptibility alleles, which may also have higher odds ratios than those detected by previous studies. GWAS was conducted in a large Ashkenazi case-control cohort, derived from the Hebrew University Genetic Resource, using the Illumina HumanOmni1-Quad BeadChip.
Link
Trefwoorden
Versies (2)
- 26-10-22 26-10-22 - Simon Heim
- 13-12-22 13-12-22 - Kristina Keller
Houder van rechten
Todd Lencz, PhD, Feinstein Institute for Medical Research, North Shore - LIJ Health System, Manhasset, NY, USA
Geüploaded op
13 december 2022
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
dbGaP phs000448 Genetics of Schizophrenia in an Ashkenazi Jewish Case-Control Cohort
Subject ID, age, place of subject birth, sex, race, diagnostic instrument, diagnosis, and age at diagnosis of participants with or without schizophrenia, obtained from the Ashkenazi Jewish population, and involved in the "Genetics of Schizophrenia in an Ashkenazi Jewish Case-Control Cohort" project.
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID, consent group, subject sources, subject source ID, and affection status of participants with or without schizophrenia, obtained from the Ashkenazi Jewish population, and involved in the "Genetics of Schizophrenia in an Ashkenazi Jewish Case-Control Cohort" project.
- Sample ID, subject ID, sample sources, sample source IDs, and sample use variables associated with participants with or without schizophrenia, obtained from the Ashkenazi Jewish population, and involved in the "Genetics of Schizophrenia in an Ashkenazi Jewish Case-Control Cohort" project.
- Subject ID, age, place of subject birth, sex, race, diagnostic instrument, diagnosis, and age at diagnosis of participants with or without schizophrenia, obtained from the Ashkenazi Jewish population, and involved in the "Genetics of Schizophrenia in an Ashkenazi Jewish Case-Control Cohort" project.
- Sample ID, analyte type [DNA], and body site where from samples were collected from participants with or without schizophrenia, obtained from the Ashkenazi Jewish population, and involved in the "Genetics of Schizophrenia in an Ashkenazi Jewish Case-Control Cohort" project.
Similar models
Subject ID, age, place of subject birth, sex, race, diagnostic instrument, diagnosis, and age at diagnosis of participants with or without schizophrenia, obtained from the Ashkenazi Jewish population, and involved in the "Genetics of Schizophrenia in an Ashkenazi Jewish Case-Control Cohort" project.
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID, consent group, subject sources, subject source ID, and affection status of participants with or without schizophrenia, obtained from the Ashkenazi Jewish population, and involved in the "Genetics of Schizophrenia in an Ashkenazi Jewish Case-Control Cohort" project.
- Sample ID, subject ID, sample sources, sample source IDs, and sample use variables associated with participants with or without schizophrenia, obtained from the Ashkenazi Jewish population, and involved in the "Genetics of Schizophrenia in an Ashkenazi Jewish Case-Control Cohort" project.
- Subject ID, age, place of subject birth, sex, race, diagnostic instrument, diagnosis, and age at diagnosis of participants with or without schizophrenia, obtained from the Ashkenazi Jewish population, and involved in the "Genetics of Schizophrenia in an Ashkenazi Jewish Case-Control Cohort" project.
- Sample ID, analyte type [DNA], and body site where from samples were collected from participants with or without schizophrenia, obtained from the Ashkenazi Jewish population, and involved in the "Genetics of Schizophrenia in an Ashkenazi Jewish Case-Control Cohort" project.
C2348585 (UMLS CUI [1,2])